The DOI matches its Crossref record; 330 of the 330 references it cites were found in a registry or an index.
Conflict of Interest in Medical Research, Education, and Practice
Abstract
Collaborations of physicians and researchers with industry can provide valuable benefits to society, particularly in the translation of basic scientific discoveries to new therapies and products. Recent reports and news stories have, however, documented disturbing examples of relationships and practices that put at risk the integrity of medical research, the objectivity of professional education, the quality of patient care, the soundness of clinical practice guidelines, and the public's trust in medicine. Conflict of Interest in Medical Research, Education, and Practice provides a comprehensive look at conflict of interest in medicine. It offers principles to inform the design of policies to identify, limit, and manage conflicts of interest without damaging constructive collaboration with industry. It calls for both short-term actions and long-term commitments by institutions and individuals, including leaders of academic medical centers, professional societies, patient advocacy groups, government agencies, and drug, device, and pharmaceutical companies. Failure of the medical community to take convincing action on conflicts of interest invites additional legislative or regulatory measures that may be overly broad or unduly burdensome. Conflict of Interest in Medical Research, Education, and Practice makes several recommendations for strengthening conflict of interest policies and curbing relationships that create risks with little benefit. The book will serve as an invaluable resource for individuals and organizations committed to high ethical standards in all realms of medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Armon, C., Argoff, C. E., Samuels, J., & Backonja, M.-M. (2007) · Neurology · doi:10.1212/01.wnl.0000256734.34238.e7 · Cited by 215
RetractedJudgment under Uncertainty: Heuristics and Biases
Tversky, A., & Kahneman, D. (1975) · Utility, Probability, and Human Decision Making · doi:10.1007/978-94-010-1834-0_8 · Cited by 22,650
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Principles of Biomedical Ethics
(2012) · Thieves of Virtue · doi:10.7551/mitpress/9079.003.0009 · Cited by 13,453
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Social Theory and Social Structure
Ross, E. J., & Merton, R. K. (1958) · The American Catholic Sociological Review · doi:10.2307/3709394 · Cited by 10,315
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Illusion and well‐being: A social psychological perspective on mental health
Taylor, S. E., & Brown, J. D. (1988) · Psychological Bulletin · doi:10.1037/0033-2909.103.2.193 · Cited by 7,814
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · cited 1×
“Several studies, based on self-reports from the authors of unpublished studies, suggest instead that authors’ decisions to not submit manuscripts with the findings of their studies account for the majority of unpublished studies (Dickersin et al., 1987, 1992; Dickersin, 1990; Easterbrook et al., 1991).”
BackgroundUsers' guides to the medical literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 2,970
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations
Grimshaw, J. M., & Russell, I. T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92244-n · Cited by 2,770
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
Self-serving biases in the attribution of causality: Fact or fiction?
Miller, D. T., & Ross, M. (1975) · Psychological Bulletin · doi:10.1037/h0076486 · Cited by 2,575
Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
Woolf, S. H., Grol, R., Hutchinson, A., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7182.527 · Cited by 2,548
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 3×
“2 Another meta-analysis that included non-English-language studies found that studies that favored a drug were four times more likely to be funded by the maker of the drug than any other sponsor (Lexchin et al., 2003).”
BackgroundResultConsensus methods: characteristics and guidelines for use
Fink, A., Kosecoff, J., Chassin, M., & Brook, R. H. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.9.979 · Cited by 2,089
Consensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Are we all less risky and more skillful than our fellow drivers?
Svenson, O. (1981) · Acta Psychologica · doi:10.1016/0001-6918(81)90005-6 · Cited by 1,969
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Beyond curriculum reform: confronting medicineʼs hidden curriculum
Hafferty, F. W. (1998) · Academic Medicine · doi:10.1097/00001888-199804000-00013 · Cited by 1,881
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816 · cited 2×
“6 times more likely to find that the drug tested was effective compared to studies without such ties (Bekelman et al., 2003).”
BackgroundResultMaloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Tunis (2003) · doi:10.1001/jama.290.12.1624 · Cited by 1,724
(2001) · PubMed · Cited by 1,709
Mowery, D. C., Nelson, R. R., Sampat, B. N., & Ziedonis, A. A. (2001) · Research Policy · doi:10.1016/s0048-7333(99)00100-6 · Cited by 1,422
The Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417
Clinical practice guidelines : directions for a new program
Field, M. J., & Lohr, K. N. (1990) · Cited by 1,415
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
Getting to Know You: Reputation and Trust in a Two-Person Economic Exchange
King-Casas, B., Tomlin, D., Anen, C., Camerer, C. F., Quartz, S. R., & Montague, P. R. (2005) · Science · doi:10.1126/science.1108062 · Cited by 1,345
The bias blind spot: perceptions of bias in self versus others
Pronin, E., Lin, D. Y., & Ross, L. (2002) · Personality and Social Psychology Bulletin · doi:10.1177/0146167202286008 · Cited by 1,289
Educational outreach visits: effects on professional practice and health care outcomes
O'Brien, M. A., Rogers, S., Jamtvedt, G., Oxman, A. D., Odgaard-Jensen, J., Kristoffersen, D. T., Forsetlund, L., Bainbridge, D., Freemantle, N., Davis, D., et al. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000409.pub2 · Cited by 1,279
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241
Clinical guidelines: Developing guidelines
Shekelle, P. G., Woolf, S. H., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7183.593 · Cited by 1,222
Users' guides to the medical literature : a manual for evidence-based clinical practice
Guyatt, G. H., Rennie, D., Meade, M. O., & Cook, D. J. (2002) · Cited by 1,196
Martinson, B. C., Anderson, M. S., & de Vries, R. (2005) · Nature · doi:10.1038/435737a · Cited by 1,096
Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making
Soumerai, S. B. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440040088034 · Cited by 1,084
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Clinical Chemistry · doi:10.1373/49.1.1 · Cited by 862
The Virtues In Medical Practice
Pellegrino, E. D., & Thomasma, D. C. (1993) · doi:10.1093/oso/9780195082890.001.0001 · Cited by 856
Dickersin, K. (1992) · JAMA · doi:10.1001/jama.1992.03480030052036 · Cited by 854
Understanding Financial Conflicts of Interest
Thompson, D. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290812 · Cited by 854
Avorn, J., & Soumerai, S. B. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082406 · Cited by 854
Shaneyfelt, T. M., Mayo-Smith, M. F., & Rothwangl, J. (1999) · JAMA · doi:10.1001/jama.281.20.1900 · Cited by 844
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 803
Updated clinical practice guidelines for the prevention and treatment of mucositis
Keefe, D. M., Schubert, M. M., Elting, L. S., Sonis, S. T., Epstein, J. B., Raber‐Durlacher, J. E., Migliorati, C. A., McGuire, D. B., Hutchins, R. D., & Peterson, D. E. (2007) · Cancer · doi:10.1002/cncr.22484 · Cited by 784
Objectivity in the eye of the beholder: Divergent perceptions of bias in self versus others
Pronin, E., Gilovich, T., & Ross, L. (2004) · Psychological Review · doi:10.1037/0033-295x.111.3.781 · Cited by 771
Uneasy alliance—clinical investigators and the pharmaceutical industry
Bodenheimer, T. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422024 · Cited by 765 · cited 1×
“Funding arrangements with contract research organizations have also raised concerns about inappropriate control by industry sponsors (Bodenheimer, 2000; Mirowski and Van Horn, 2005; Shuchman, 2007; Lenzer, 2008).”
BackgroundChapman, S. W., Dismukes, W. E., Proia, L. A., Bradsher, R. W., Pappas, P. G., Threlkeld, M. G., & Kauffman, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/588300 · Cited by 759
Full Disclosure: The Perils and Promise of Transparency
Fung, A., Graham, M., & Weil, D. (2007) · doi:10.1017/cbo9780511510533 · Cited by 752
Publication bias and clinical trials
Dickersin, K., Chan, S., Chalmersx, T. C., Sacks, H. S., & Smith, H. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90155-3 · Cited by 715
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., et al. (2006) · JAMA · doi:10.1001/jama.295.4.429 · Cited by 695
Practice guidelines developed by specialty societies: the need for a critical appraisal
Grilli, R., Magrini, N., Penna, A., Mura, G., & Liberati, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)02171-6 · Cited by 664
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
Choudhry, N. K. (2002) · JAMA · doi:10.1001/jama.287.5.612 · Cited by 646
Melander, H., Ahlqvist-Rastad, J., Meijer, G., & Beermann, B. (2003) · BMJ · doi:10.1136/bmj.326.7400.1171 · Cited by 635
Naghavi, M., Falk, E., Hecht, H. S., Jamieson, M. J., Kaul, S., Berman, D., Fayad, Z., Budoff, M. J., Rumberger, J., Naqvi, T. Z., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.002 · Cited by 635
Grimshaw, J., Eccles, M., Thomas, R., MacLennan, G., Ramsay, C., Fraser, C., & Vale, L. (2006) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0269-7 · Cited by 631
Moore, D. A., Tetlock, P. E., Tanlu, L., & Bazerman, M. H. (2006) · Academy of Management Review · doi:10.5465/amr.2006.19379621 · Cited by 631
The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest
Cain, D. M., Loewenstein, G., & Moore, D. A. (2005) · The Journal of Legal Studies · doi:10.1086/426699 · Cited by 614
A Social Science Perspective on Gifts to Physicians From Industry
Dana, J. (2003) · JAMA · doi:10.1001/jama.290.2.252 · Cited by 594
Migraine and Risk of Cardiovascular Disease in Women
Kurth, T., Gaziano, J. M., Cook, N. R., Logroscino, G., Diener, H.-C., & Buring, J. E. (2006) · JAMA · doi:10.1001/jama.296.3.283 · Cited by 580
Withholding Research Results in Academic Life Science: Evidence From a National Survey of Faculty
Blumenthal, D. (1997) · JAMA · doi:10.1001/jama.1997.03540390054035 · Cited by 576
Prevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals
Flanagin, A. (1998) · JAMA · doi:10.1001/jama.280.3.222 · Cited by 553
A National Survey of Physician–Industry Relationships
Campbell, E. G., Gruen, R. L., Mountford, J., Miller, L. G., Cleary, P. D., & Blumenthal, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064508 · Cited by 553
Developing and Testing Changes in Delivery of Care
Berwick, D. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-8-199804150-00009 · Cited by 526
Wilson, J. W., Ott, C. M., zu Bentrup, K. H., Ramamurthy, R., Quick, L., Porwollik, S., Cheng, P., McClelland, M., Tsaprailis, G., Radabaugh, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707155104 · Cited by 516
Gagnon, M.-A., & Lexchin, J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050001 · Cited by 502
Data Withholding in Academic Genetics: Evidence From a National Survey
Campbell, E. G., Clarridge, B. R., Gokhale, M., Birenbaum, L., Hilgartner, S., Holtzman, N. A., & Blumenthal, D. (2002) · JAMA · doi:10.1001/jama.287.4.473 · Cited by 489
The neural substrates of reward processing in humans: the modern role of FMRI
McClure, S. M., York, M. K., & Montague, P. R. (2004) · The Neuroscientist · doi:10.1177/1073858404263526 · Cited by 480
Participation of Life-Science Faculty in Research Relationships with Industry
Blumenthal, D., Campbell, E. G., Causino, N., & Louis, K. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352305 · Cited by 461
Shiffman, R. N., Shekelle, P., Overhage, J. M., Slutsky, J., Grimshaw, J., & Deshpande, A. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00013 · Cited by 451
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Financial Anatomy of Biomedical Research
Moses, H., Dorsey, E. R., Matheson, D. H. M., & Thier, S. O. (2005) · JAMA · doi:10.1001/jama.294.11.1333 · Cited by 447
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
Chan, A.-W. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041086 · Cited by 444
Why review articles on the health effects of passive smoking reach different conclusions
Barnes, D. E. (1998) · JAMA · doi:10.1001/jama.279.19.1566 · Cited by 442
An Introduction to Meta–Analysis
Konstantopoulos, S. (2008) · Best Practices in Quantitative Methods · doi:10.4135/9781412995627.d15 · Cited by 432
Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles
Lesser, L. I., Ebbeling, C. B., Goozner, M., Wypij, D., & Ludwig, D. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040005 · Cited by 421
Messick, D. M., & Sentis, K. P. (1979) · Journal of Experimental Social Psychology · doi:10.1016/0022-1031(79)90047-7 · Cited by 407
Relationships between Academic Institutions and Industry in the Life Sciences — An Industry Survey
Blumenthal, D., Causino, N., Campbell, E., & Louis, K. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340606 · Cited by 401
Chren, M. M. (1994) · JAMA · doi:10.1001/jama.271.9.684 · Cited by 397
Steinman, M. A., Shlipak, M. G., & McPhee, S. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00660-x · Cited by 383
Hillman, B. J., Joseph, C. A., Mabry, M. R., Sunshine, J. H., Kennedy, S. D., & Noether, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012063232306 · Cited by 356
Katz, D., Caplan, A. L., & Merz, J. F. (2010) · The American Journal of Bioethics · doi:10.1080/15265161.2010.519226 · Cited by 355
Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs
BURGERS, J. S. (2003) · International Journal for Quality in Health Care · doi:10.1093/intqhc/15.1.31 · Cited by 331
Rising, K., Bacchetti, P., & Bero, L. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050217 · Cited by 328
Pharmaceutical company funding and its consequences: A qualitative systematic review
Sismondo, S. (2008) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.08.001 · Cited by 304
Self-Serving Assessments of Fairness and Pretrial Bargaining
Loewenstein, G., Issacharoff, S., Camerer, C., & Babcock, L. (1993) · The Journal of Legal Studies · doi:10.1086/468160 · Cited by 292
Trial Registration at ClinicalTrials.gov between May and October 2005
Zarin, D. A., Tse, T., & Ide, N. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa053234 · Cited by 291
Ghost Authorship in Industry-Initiated Randomised Trials
Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A.-W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040019 · Cited by 289
Pay for Performance at the Tipping Point
Epstein, A. M. (2007) · New England Journal of Medicine · doi:10.1056/nejme078002 · Cited by 276
Financial Incentives for Physicians in HMOs
Hillman, A. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172725 · Cited by 272
Sponsorship, Authorship, and Accountability
Davidoff, F. (2001) · New England Journal of Medicine · doi:10.1056/nejmed20010093 · Cited by 270
Academic Detailing to Improve Use of Broad-Spectrum Antibiotics at an Academic Medical Center
Solomon, D. H., Van Houten, L., Glynn, R. J., Baden, L., Curtis, K., Schrager, H., & Avorn, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1897 · Cited by 270
Improving the Use of Research Evidence in Guideline Development
Oxman, A. D., Schünemann, H. J., Fretheim, A., Boyd, E. A., Bero, L. A., & Edejer, T. T.-T. (2007) · BIBSYS Brage (BIBSYS (Norway)) · Cited by 261
Farrell, R. J., Ang, Y., Kileen, P., O'Briain, D. S., Kelleher, D., Keeling, P. W. N., & Weir, D. G. (2000) · Gut · doi:10.1136/gut.47.4.514 · Cited by 260
The Contract Research Organization and the Commercialization of Scientific Research
Mirowski, P., & Van Horn, R. (2005) · Social Studies of Science · doi:10.1177/0306312705052103 · Cited by 260
Bero, L., Oostvogel, F., Bacchetti, P., & Lee, K. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040184 · Cited by 249
Dealing with Conflicts of Interest
Relman, A. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131209 · Cited by 249
Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry
Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091772 · Cited by 248
Knowing What Works in Health Care: A Roadmap for the Nation
Eden, J., Wheatley, B., McNeil, B., & Sox, H. C. (2008) · University Libraries (University of Maryland) · doi:10.13016/zoku-ylou · Cited by 246
Paying Physicians for High-Quality Care
(2004) · New England Journal of Medicine · doi:10.1056/nejm200404293501822 · Cited by 244
Blumenthal, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmhpr042734 · Cited by 238
Yank, V., Rennie, D., & Bero, L. A. (2007) · BMJ · doi:10.1136/bmj.39376.447211.be · Cited by 235 · cited 1×
“As discussed in Chapter 4, which describes additional studies, a review of meta-analyses on hypertensive drugs found that financial ties to a single pharmaceutical company were not associated with findings that favored the company but were associated with favorable conclusions (Yank et al., 2007).”
ResultMotivated Reasoning and Performance on the was on Selection Task
Dawson, E., Gilovich, T., & Regan, D. T. (2002) · Personality and Social Psychology Bulletin · doi:10.1177/014616702236869 · Cited by 235
Evidence-Based Strategies for Implementing Guidelines in Obstetrics: A Systematic Review
Chaillet, N., Dubé, E., Dugas, M., Audibert, F., Tourigny, C., Fraser, W. D., & Dumont, A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000236434.74160.8b · Cited by 233
Following the Script: How Drug Reps Make Friends and Influence Doctors
Fugh-Berman, A., & Ahari, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040150 · Cited by 233
Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
DeAngelis, C. D., & Fontanarosa, P. B. (2008) · JAMA · doi:10.1001/jama.299.15.1833 · Cited by 230
Prevalence of Honorary and Ghost Authorship in Cochrane Reviews
Mowatt, G. (2002) · JAMA · doi:10.1001/jama.287.21.2769 · Cited by 227
Influences on the Quality of Published Drug Studies
Bero, L. A., & Rennie, D. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009582 · Cited by 226
A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical Research
McCrary, S. V., Anderson, C. B., Jakovljevic, J., Khan, T., McCullough, L. B., Wray, N. P., & Brody, B. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432207 · Cited by 225
Policies on Faculty Conflicts of Interest at US Universities
Cho, M. K. (2000) · JAMA · doi:10.1001/jama.284.17.2203 · Cited by 224
Frances, R. J. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70411-0 · Cited by 220
Snyder, L., Leffler, C., & for the Ethics and Human Rights Committee, A. C. O. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00014 · Cited by 219
Responsible Research: A Systems Approach to Protecting Research Participants
Federman, D. D., Hanna, K. E., & Rodriguez, L. L. (2013) · Cited by 218
Conflict-of-Interest Policies for Investigators in Clinical Trials
Lo, B., Wolf, L. E., & Berkeley, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432206 · Cited by 218
Interface between authorship, industry and science in the domain of therapeutics
Healy, D., & Cattell, D. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.1.22 · Cited by 218
Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis
Lee, K., Bacchetti, P., & Sim, I. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050191 · Cited by 215 · cited 2×
“In addition, a study of materials submitted to the FDA in support of successful new drug applications found that clinical trials with statistically favorable results were almost twice as likely to be published as industryfunded studies that did not have favorable results (Lee et al., 2008).”
BackgroundResultA comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts
Gibbons, R. V., Landry, F. J., Blouch, D. L., Jones, D. L., Williams, F. K., Lucey, C. R., & Kroenke, K. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00048.x · Cited by 197
Medical Students’ Exposure to and Attitudes About Drug Company Interactions: A National Survey
Sierles, F. S., Brodkey, A. C., Cleary, L. M., McCurdy, F. A., Mintz, M., Frank, J., Lynn, D. J., Chao, J., Morgenstern, B. Z., Shore, W., et al. (2005) · JAMA · doi:10.1001/jama.294.9.1034 · Cited by 196
Krimsky, S., & Rothenberg, L. S. (2001) · Science and Engineering Ethics · doi:10.1007/s11948-001-0041-7 · Cited by 191
A Controlled Trial of Teaching Critical Appraisal of the Clinical Literature to Medical Students
Bennett, K. J. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390180069025 · Cited by 187
Rating the strength of scientific evidence: relevance for quality improvement programs
Lohr, K. N. (2004) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzh005 · Cited by 186
Separating Continuing Medical Education From Pharmaceutical Marketing
Relman, A. S. (2001) · JAMA · doi:10.1001/jama.285.15.2009 · Cited by 180
Institutional Academic−Industry Relationships
Campbell, E. G., Weissman, J. S., Ehringhaus, S., Rao, S. R., Moy, B., Feibelmann, S., & Goold, S. D. (2007) · JAMA · doi:10.1001/jama.298.15.1779 · Cited by 176
Financial Associations of Authors
Drazen, J. M., & Curfman, G. D. (2002) · New England Journal of Medicine · doi:10.1056/nejme020074 · Cited by 176
Psaty, B. M., & Kronmal, R. A. (2008) · JAMA · doi:10.1001/jama.299.15.1813 · Cited by 173
McCormick, B. B. (2001) · JAMA · doi:10.1001/jama.286.16.1994 · Cited by 171
Outcomes of evidence-based clinical practice guidelines: A systematic review
Bahtsevani, C., Udén, G., & Willman, A. (2004) · International Journal of Technology Assessment in Health Care · doi:10.1017/s026646230400131x · Cited by 170
The politics of expertise in Congress: the rise and fall of the Office of Technology Assessment
(1997) · Choice Reviews Online · doi:10.5860/choice.34-3002 · Cited by 170
Nonfinancial Conflicts of Interest in Research
Levinsky, N. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmsb020853 · Cited by 168
Interactions between pharmaceutical representatives and doctors in training: A thematic review
Zipkin, D. A., & Steinman, M. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0134.x · Cited by 167
DeAngelis, C. D. (2001) · JAMA · doi:10.1001/jama.286.1.89 · Cited by 166
The Publication of Sponsored Symposiums in Medical Journals
Bero, L. A., Galbraith, A., & Rennie, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271606 · Cited by 164
McKinney, W. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450130065028 · Cited by 163
Lu, C. Y., Ross‐Degnan, D., Soumerai, S. B., & Pearson, S. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-75 · Cited by 162
Takuo Aoyagi: Discovery of Pulse Oximetry
Severinghaus, J. W. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000269514.31660.09 · Cited by 161
Vinoski, S. (2004) · IEEE Internet Computing · doi:10.1109/mic.2004.1260709 · Cited by 159
Do drug samples influence resident prescribing behavior? A randomized trial
Adair, R. F., & Holmgren, L. R. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.031 · Cited by 157
Campbell, S., Hann, M., Roland, M. O., Quayle, J. A., & Shekelle, P. (1999) · Medical Care · doi:10.1097/00005650-199909000-00012 · Cited by 157
Rochon, P. A., Gurwitz, J. H., Cheung, C. M., Hayes, J. A., & Chalmers, T. C. (1994) · JAMA · doi:10.1001/jama.1994.03520020034009 · Cited by 156
Pharmaceutical representatives in academic medical centers
Lurie, N., Rich, E. C., SIMPSON, D. E., Meyer, J., Schiedermayer, D. L., Goodman, J. L., & McKinney, W. P. (1990) · Journal of General Internal Medicine · doi:10.1007/bf02600542 · Cited by 154
Sources of bias for authors of clinical practice guidelines
Detsky, A. S. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.061181 · Cited by 150
An emerging consensus on grading recommendations?
Guyatt, G. H., Vist, G., Falck-Ytter, Y., Kunz, R., Magrini, N., & Schunemann, H. (2006) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.11.1.2-a · Cited by 148
The Messenger under Attack — Intimidation of Researchers by Special-Interest Groups
Deyo, R. A., Psaty, B. M., Simon, G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361611 · Cited by 147
Patients' Views on Financial Conflicts of Interest in Cancer Research Trials
Hampson, L. A., Agrawal, M., Joffe, S., Gross, C. P., Verter, J. I., & Emanuel, E. J. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa064160 · Cited by 146
Physicians and Drug Representatives: Exploring the Dynamics of the Relationship
Chimonas, S. C., Brennan, T. A., & Rothman, D. J. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0041-z · Cited by 145
The ADVANTAGE Seeding Trial: A Review of Internal Documents
Hill, K. P., Ross, J. S., Egilman, D. S., & Krumholz, H. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00006 · Cited by 142
Regulating Academic–Industrial Research Relationships — Solving Problems or Stifling Progress?
Stossel, T. P. (2005) · New England Journal of Medicine · doi:10.1056/nejmsb051758 · Cited by 140
Professional Medical Associations
Pellegrino, E. D., & Relman, A. S. (1999) · JAMA · doi:10.1001/jama.282.10.984 · Cited by 140
Lurie, P. G., Almeida, C. M., Stine, N. W., Stine, A., & Wolfe, S. M. (2006) · JAMA · doi:10.1001/jama.295.16.1921 · Cited by 139
Medical Innovation and Institutional Interdependence
Gelijns, A. C., & Thier, S. O. (2002) · JAMA · doi:10.1001/jama.287.1.72 · Cited by 139
Responsiveness of Physician Prescription Behavior to Salesforce Effort: An Individual Level Analysis
Manchanda, P., & Chintagunta, P. K. (2004) · Marketing Letters · doi:10.1023/b:mark.0000047389.93584.09 · Cited by 139
Steinbrook, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068282 · Cited by 139
Evidence-Based Coverage Policy
Garber, A. M. (2001) · Health Affairs · doi:10.1377/hlthaff.20.5.62 · Cited by 138
A critical review of guidelines for low back pain treatment
Arnau, J. M., Vallano, A., López, A., Pellisé, F., Delgado, M. J., & Prat, N. (2005) · European Spine Journal · doi:10.1007/s00586-005-1027-y · Cited by 136
Manchanda, P., & Honka, E. (2005) · PubMed · Cited by 134
Fontanarosa, P., Flanagin, A., & DeAngelis, C. D. (2005) · JAMA · doi:10.1001/jama.294.1.110 · Cited by 134
The Neurontin Legacy — Marketing through Misinformation and Manipulation
Landefeld, C. S., & Steinman, M. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0808659 · Cited by 133
Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry
Mello, M. M., Clarridge, B. R., & Studdert, D. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044115 · Cited by 132
Academic Relationships With Industry: A New Model for Biomedical Research
Moses, H., & Martin, J. B. (2001) · JAMA · doi:10.1001/jama.285.7.933 · Cited by 132
Wegman, A. C. M., van der Windt, D., van Tulder, M. W., Stalman, W. A. B., & de Vries, T. P. G. M. (2004) · PubMed · Cited by 132
Reporting of 6-Month vs 12-Month Data in a Clinical Trial of Celecoxib
Hrachovec, J. B., & Mora, M. (2001) · JAMA · doi:10.1001/jama.286.19.2398-c · Cited by 127
Interactions of doctors with the pharmaceutical industry
Morgan, M., Dana, J. D., Loewenstein, G. F., Zinberg, S., & Schulkin, J. A. (2006) · Journal of Medical Ethics · doi:10.1136/jme.2005.014480 · Cited by 127
van Eijk, M. E. C., Avorn, J., Porsius, A. J., & de Boer, A. (2001) · BMJ · doi:10.1136/bmj.322.7287.654 · Cited by 125
Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals
Cooper, R. J., Gupta, M., Wilkes, M. S., & Hoffman, J. R. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00598.x · Cited by 125
Commercializing Clinical Trials — Risks and Benefits of the CRO Boom
Shuchman, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078176 · Cited by 124
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn, J., Blood, E., Winer, E., & Partridge, A. (2007) · Cancer · doi:10.1002/cncr.22528 · Cited by 123
Enhancing the Informal Curriculum of a Medical School: A Case Study in Organizational Culture Change
Cottingham, A. H., Suchman, A. L., Litzelman, D. K., Frankel, R. M., Mossbarger, D. L., Williamson, P. R., Baldwin, D. C., & Inui, T. S. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0543-y · Cited by 121
Does declaration of competing interests affect readers' perceptions? A randomised trial
Chaudhry, S., Schroter, S., Smith, R., & Morris, J. (2002) · BMJ · doi:10.1136/bmj.325.7377.1391 · Cited by 120
Institutional Conflict of Interest
Emanuel, E. J., & Steiner, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320412 · Cited by 116
A review of journal policies for sharing research dataPreprint
Piwowar, H., & Chapman, W. W. (2008) · Nature Precedings · doi:10.1038/npre.2008.1700.1 · Cited by 116
Lenzer, J., Warlow, C., Saver, J. L., Kidwell, C. S., & Starkman, S. (2002) · BMJ · doi:10.1136/bmj.324.7339.723 · Cited by 115
Johns, M. M. E., Barnes, M. R., & Florencio, P. S. (2003) · JAMA · doi:10.1001/jama.289.6.741 · Cited by 113
Guirguis‐Blake, J., Calonge, N., Miller, T., Siu, A. L., Teutsch, S. M., Whitlock, E. P., & for the U.S. Preventive Services Task Force (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-2-200707170-00170 · Cited by 113
Ancker, J. S., & Flanagin, A. (2007) · Science and Engineering Ethics · doi:10.1007/s11948-007-9011-z · Cited by 112
Financial Relationships between Institutional Review Board Members and Industry
Campbell, E. G., Weissman, J. S., Vogeli, C., Clarridge, B. R., Abraham, M. E., Marder, J. E., & Koski, G. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa061457 · Cited by 112
Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry
Brody, H. A. (2006) · Cited by 111
Kim, S. Y. H., Millard, R., Nisbet, P. A., Cox, C., & Caine, E. (2004) · Journal of Medical Ethics · doi:10.1136/jme.2002.001461 · Cited by 109
Evidence Based? Caveat Emptor!
Steinberg, E. P., & Luce, B. R. (2005) · Health Affairs · doi:10.1377/hlthaff.24.1.80 · Cited by 109
Conflict of interest in the professions
(2002) · Choice Reviews Online · doi:10.5860/choice.39-6351 · Cited by 104
Looking a Gift Horse in the Mouth
Campbell, E. G., Louis, K. S., & Blumenthal, D. (1998) · JAMA · doi:10.1001/jama.279.13.995 · Cited by 104
AHCPR And The Changing Politics Of Health Services Research
Gray, B. H., Gusmano, M. K., & Collins, S. R. (2003) · Health Affairs · doi:10.1377/hlthaff.w3.283 · Cited by 104
Lessons From the Failure and Recall of an Implantable Cardioverter-Defibrillator
Hauser, R. G., & Maron, B. J. (2005) · Circulation · doi:10.1161/circulationaha.105.580381 · Cited by 102
Sustained microgravity reduces intrinsic wound healing and growth factor responses in the rat
Davidson, J. M., Aquino, A. M., WOODWARD, S. C., & Wilfinger, W. W. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.325 · Cited by 99
Financial Pressures Spur Physician Entrepreneurialism
Pham, H. H., Devers, K. J., May, J. H., et al. (2004) · Health Affairs · doi:10.1377/hlthaff.23.2.70 · Cited by 98
The cost effectiveness of occupational health interventions: Prevention of silicosis
Lahiri, S., Levenstein, C., Nelson, D. I., & Rosenberg, B. J. (2005) · American Journal of Industrial Medicine · doi:10.1002/ajim.20222 · Cited by 97
The specificity of JAK3 kinase inhibitors
Changelian, P. S., Moshinsky, D. J., Kuhn, C. F., Flanagan, M. E., Munchhof, M. J., Harris, T. M., Whipple, D. A., Doty, J. L., Sun, J., Kent, C. R., et al. (2007) · Blood · doi:10.1182/blood-2007-09-115030 · Cited by 96
Study of information submitted by drug companies to licensing authorities.
Hemminki, E. (1980) · BMJ · doi:10.1136/bmj.280.6217.833 · Cited by 96
Intangibility in intertemporal choice
Rick, S., & Loewenstein, G. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0150 · Cited by 95
Cited by
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Neunert, C., Terrell, D. R., Arnold, D. M., Buchanan, G., Cines, D. B., Cooper, N., Cuker, A., Despotovic, J. M., George, J. N., Grace, R. F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000966 · Cited by 1,406
Best care at lower cost: the path to continuously learning health care in America
(2014) · Choice Reviews Online · doi:10.5860/choice.51-3277 · Cited by 1,363
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902
Lyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
Metadata
- Venue
- National Academies Press eBooks
- Publisher
- National Academies Press
- Published
- 2009-09-16
- OpenAlex
- W1585254192
- Cited by
- 807
- References
- 330
- FWCI
- 72.53
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.